FENC - CIK 0001211583
The table below shows FENNEC PHARMACEUTICALS INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $44.64M | $47.54M | $21.25M | $1.53M | - | $200.00K |
| Cost of revenue | - | - | $1.26M | $86.00K | - | - |
| Gross profit | - | - | $19.99M | $1.45M | - | - |
| R&D | $250.00K | $307.00K | $56.00K | $3.53M | $4.98M | $5.11M |
| SG&A |
FENNEC PHARMACEUTICALS INC. reported annual revenue of $44.64M for fiscal year 2025. That is down 6.1% from $47.54M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $28.29M |
| $23.05M |
| $20.59M |
| $17.72M |
| $12.24M |
| $12.95M |
| Operating income | -$6.28M | $2.57M | -$12.77M | -$22.59M | -$17.22M | -$17.89M |
| Income tax | $106.00K | $365.00K | - | $0.00 | $0.00 | $0.00 |
| Net income | -$9.74B | -$436.00M | -$16.05B | -$23.71M | -$17.35M | -$18.11M |
| EPS (diluted) | -$0.34 | -$0.02 | -$0.60 | -$0.90 | -$0.67 | -$0.76 |